These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33392905)

  • 1. Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS).
    Yarosh R; Roesler MA; Murray T; Cioc A; Hirsch B; Nguyen P; Warlick E; Poynter JN
    Cancer Causes Control; 2021 Mar; 32(3):241-250. PubMed ID: 33392905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study.
    Poynter JN; Richardson M; Roesler M; Blair CK; Hirsch B; Nguyen P; Cioc A; Cerhan JR; Warlick E
    Int J Cancer; 2017 Jan; 140(1):23-33. PubMed ID: 27603749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy-related acute myeloid leukaemia and myelodysplastic syndrome in Victoria, Australia 2003-2014.
    Ong DM; Farrugia H; Wei A
    Intern Med J; 2018 Jul; 48(7):822-829. PubMed ID: 29236346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological comparison of dysplastic changes between de novo acute myeloid leukemia (AML) with trilineage myelodysplasia and AML developed from de novo myelodysplastic syndromes.
    Kuriyama K; Miyazaki Y; Arimura K; Nagai K; Nakamura H; Matsuo T; Tomonaga M
    Leuk Res; 1995 Feb; 19(2):121-5. PubMed ID: 7869740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personal history of autoimmune disease and other medical conditions and risk of myelodysplastic syndromes.
    Linabery AM; Roesler MA; Richardson M; Warlick ED; Nguyen PL; Cioc AM; Poynter JN
    Cancer Epidemiol; 2022 Feb; 76():102090. PubMed ID: 34995873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes.
    Kristinsson SY; Björkholm M; Hultcrantz M; Derolf ÅR; Landgren O; Goldin LR
    J Clin Oncol; 2011 Jul; 29(21):2897-903. PubMed ID: 21690473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for myelodysplastic syndromes: a case-control study in Greece.
    Dalamaga M; Petridou E; Cook FE; Trichopoulos D
    Cancer Causes Control; 2002 Sep; 13(7):603-8. PubMed ID: 12296507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
    Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
    J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occupational, dietary, and other risk factors for myelodysplastic syndromes in Western Greece.
    Avgerinou C; Giannezi I; Theodoropoulou S; Lazaris V; Kolliopoulou G; Zikos P; Alamanos Y; Leotsinidis M; Symeonidis A
    Hematology; 2017 Aug; 22(7):419-429. PubMed ID: 28102107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative risk of myelodysplastic syndromes in patients with autoimmune disorders in the General Practice Research Database.
    Wilson AB; Neogi T; Prout M; Jick S
    Cancer Epidemiol; 2014 Oct; 38(5):544-9. PubMed ID: 25189344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental and occupational determinants of myelodysplastic syndrome: A case-control study from Pakistan.
    Anwar N; Arshad A; Fatima N; Shaheen S; Bukhari S; Shamsi T
    Cancer Rep (Hoboken); 2022 Oct; 5(10):e1580. PubMed ID: 34708590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
    Mauritzson N; Albin M; Rylander L; Billström R; Ahlgren T; Mikoczy Z; Björk J; Strömberg U; Nilsson PG; Mitelman F; Hagmar L; Johansson B
    Leukemia; 2002 Dec; 16(12):2366-78. PubMed ID: 12454741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of myelodysplastic syndromes: a case-control study.
    Strom SS; Gu Y; Gruschkus SK; Pierce SA; Estey EH
    Leukemia; 2005 Nov; 19(11):1912-8. PubMed ID: 16167059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De-novo acute myeloid leukemia with trilineage myelodysplasia (AML/TMDS) and myelodysplastic remission marrow (AML/MRM).
    Tamura S; Kanamaru A
    Leuk Lymphoma; 1995 Jan; 16(3-4):263-70. PubMed ID: 7719234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol use is not a significant contributor to myelodysplastic syndromes.
    Duffy EA; Nguyen PL; Cioc A; Warlick E; Roesler MA; Poynter JN
    Cancer Causes Control; 2020 Jun; 31(6):549-557. PubMed ID: 32285234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia.
    Ertz-Archambault N; Kosiorek H; Taylor GE; Kelemen K; Dueck A; Castro J; Marino R; Gauthier S; Finn L; Sproat LZ; Palmer J; Mesa RA; Al-Kali A; Foran J; Tibes R
    JAMA Oncol; 2017 Jul; 3(7):936-943. PubMed ID: 28152123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases.
    Merlat A; Lai JL; Sterkers Y; Demory JL; Bauters F; Preudhomme C; Fenaux P
    Leukemia; 1999 Feb; 13(2):250-7. PubMed ID: 10025899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
    Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
    Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tea consumption reduces the risk of de novo myelodysplastic syndromes.
    Liu P; Zhang M; Jin J; Holman CD
    Leuk Res; 2015 Feb; 39(2):164-9. PubMed ID: 25529769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between non-steroidal anti-inflammatory drugs (NSAIDs) and myelodysplastic syndromes in the Adults in Minnesota with Myelodysplastic Syndromes (AIMMS) Study.
    Hubbard AK; Richardson M; Rosesler MA; Cioc A; Nguyen PL; Warlick E; Poynter JN
    Leuk Lymphoma; 2021 Jun; 62(6):1474-1481. PubMed ID: 33416407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.